Genome instability is a hallmark of cancer and involves frequent mutations, chromosomal alterations, and aneuploidy. These changes can disrupt key regulatory genes such as oncogenes and tumor suppressor genes, leading to uncontrolled cell growth and tumor formation. For instance, mutations in the TP53 gene, which encodes the p53 protein, can impair the cell’s ability to undergo apoptosis in response to DNA damage.
